Comments
Loading...
Regenxbio (RGNX) Forecast
NewsEarningsRegenxbio (RGNX) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestRegenxbio (NASDAQ:RGNX) Stock Quotes, Forecast and News Summary
Regenxbio Stock (NASDAQ: RGNX) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Regenxbio (RGNX) stock?
You can purchase shares of Regenxbio (NASDAQ:RGNX) through any online brokerage.
Who are Regenxbio (RGNX) competitors?
Other companies in Regenxbio’s space includes: aTyr Pharma (NASDAQ:ATYR), Monte Rosa Therapeutics (NASDAQ:GLUE), Ironwood Pharmaceuticals (NASDAQ:IRWD), Olema Pharmaceuticals (NASDAQ:OLMA) and Design Therapeutics (NASDAQ:DSGN).
What is the forecast, or price target, for Regenxbio (RGNX) stock?
Regenxbio has a consensus price target of $35.40.
What is the current price for Regenxbio (RGNX)?
The stock price for Regenxbio (NASDAQ: RGNX) is $7.34 last updated February 21, 2025 at 12:33 PM EST.
Does Regenxbio (RGNX) pay a dividend?
There are no upcoming dividends for Regenxbio.
When is Regenxbio (NASDAQ:RGNX) reporting earnings?
Regenxbio’s Q1 earnings are confirmed for Wednesday, May 7, 2025.
Is Regenxbio (RGNX) going to split?
There is no upcoming split for Regenxbio.
What sector and industry does Regenxbio (RGNX) operate in?
Regenxbio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.